Inventor · disambiguated record
Yoshinobu Higuchi
Also filed as: HIGUCHI YOSHINOBU
11 granted patents·12 pending applications·186 citations·filing 1997–2025
90Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD14IGAWA TOMOYUKI2DENKI KAGAKU KOGYO KK1HIGUCHI YOSHINOBU1IKEYA HITOSHI1
Top patents by PatentIndex Score
23 records- 0198US8562991B2Antibody molecules that bind to IL-6 receptorIGAWA TOMOYUKI·Filed 2009·Granted Oct 22, 2013·130 cites·19 claims
- 0296US10662245B2Methods of reducing IL-6 activity for disease treatmentCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted May 26, 2020·22 cites·25 claims
- 0393US2025101118A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0492US2025346677A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0591US2024301075A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0690US10544227B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 28, 2020·8 cites·12 claims
- 0788US2024010738A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0886US2023159648A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0984US8431127B2Method for treating pruritus comprising administering an NR10 antagonistHIGUCHI YOSHINOBU·Filed 2008·Granted Apr 30, 2013·15 cites·19 claims
- 1083US11773173B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 3, 2023·2 cites·18 claims
- 1183US2022306755A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1280US2022041741A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1379US12441804B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Oct 14, 2025·0 cites·16 claims
- 1478US8088916B2Hyaluronic acid-methotrexate conjugateIKEYA HITOSHI·Filed 2005·Granted Jan 3, 2012·4 cites·9 claims
- 1574US2020231688A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1671US7807675B2Hyaluronic acid-methotrexate conjugateDENKI KAGAKU KOGYO KK·Filed 2005·Granted Oct 5, 2010·2 cites·10 claims
- 1768US8318658B2Cell calcification suppressing proteins, and genes of the proteinsIWAMOTO MASAHIRO·Filed 2009·Granted Nov 27, 2012·0 cites·3 claims
- 1866US7494970B2Cell calcification suppressing proteins, and genes of the proteinsUNIV PENNSYLVANIA·Filed 2004·Granted Feb 24, 2009·0 cites·10 claims
- 1963US2012253016A1Antibody molecules that bind to il-6 receptorIGAWA TOMOYUKI·Filed 2012·Application pending·0 cites
- 2060US2004204342A1Orthodontic remedies containingCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 2155US2002164739A1Cell calcification supressing proteins, and genes of the proteinsCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Application pending·0 cites
- 2245US6294354B1Cell calcification supressing proteins, and genes of the proteinsFiled 1997·Granted Sep 25, 2001·3 cites·9 claims
- 2329US2003035780A1Orthodontic remedies containing pthFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshinobu Higuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →